We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
CanSino Biologics has enrolled more than 20,000 participants in a global phase 3 study of its COVID-19 vaccine candidate, Ad5-nCoV, co-developed with a research arm of the Chinese military. Read More
The House Select Subcommittee on the Coronavirus Crisis issued subpoenas on Monday to the chiefs of HHS and the Centers for Disease Control and Prevention (CDC), demanding documents relating to the Democrats’ investigation of alleged political tampering with coronavirus response efforts. Read More
Ending months of haggling between lawmakers, Congress passed an omnibus appropriations bill and COVID-19 relief package late Monday with a seven-day continuing resolution in place to keep the government funded at fiscal 2020 levels until the legislation is signed into law as expected. Read More
Vaccinations using Pfizer/BioNTech’s COVID-19 vaccine are set to begin Sunday throughout Europe, following the European Commission’s landmark authorization of its first coronavirus vaccine. Read More
Novartis has received a Complete Response Letter (CRL) from the FDA regarding a new drug application (NDA) for its cholesterol-lowering drug Leqvio (inclisiran). Read More
The World Health Organization has announced that its COVAX program has now reached supply agreements for almost 2 billion doses of several promising COVID-19 vaccine candidates for distribution to less well-off countries next year. Read More
Oxford University released new trial data last week that raises further questions about the most effective dosing regimen for Oxford’s COVID-19 vaccine candidate, AZD1222, that is being co-developed with AstraZeneca and how it came to pass that two different dosing regimens were pursued. Read More
The FDA has announced that it is investigating multiple reports of allergic reactions to Pfizer/BioNTech’s COVID-19 vaccine as supplies of the shot continue to roll out across the U.S. this week. Read More
The House and Senate are expected to vote today on a combined fiscal 2021 appropriations and COVID-19 relief legislative package after passing another stopgap spending bill Sunday to keep the federal government funded for 24 hours. Read More